A patient has died in a mid-stage study of MacroGenics’ bispecific antibody lorigerlimab in gynecologic cancers, prompting ...

How HRD and BRCA results steer frontline ovarian cancer maintenance—niraparib vs olaparib—plus guidance on recurrence, ...

Cancer care services for women has gotten a boost with a $10 million gift to Naples Comprehensive Health, NCH, in Collier ...

The FDA placed a partial hold on a phase 2 lorigerlimab trial in gynecologic cancers after a patient died from grade 4 ...

Live webcast of event on February 27 at 8:00 a.m. ET will include participation of globally renowned gynecological oncology KOLs from the US and ...

Neoadjuvant chemotherapy increasingly matches upfront debulking outcomes, reducing extreme surgery risks while highlighting why patients still need access to R0 radical resection.

Breast exams, birth control and family planning are just some of the reasons not to skip your annual ob-gyn appointment.

Over the past decade, significant advances in molecular biology, genomics, immunology, and bioinformatics have reshaped our understanding of gynecologic ...

Oregon is poised to become the first state in the nation to eliminate out-of-pocket costs for follow-up testing after an abnormal cervical cancer screening. The Oregon House on Wednesday unanimously ...

Episcopal Health Services has opened a new cancer center in Far Rockaway, the health system said this week, aiming to fill a decade-long void in oncology services on the peninsula. The cancer center ...

This article appears in print in the April 2020 issue as part of the Top Doctors (Cancer Specialties) cover story. Click here to subscribe. Michelle F. Benoit, M.D., robotic surgery, gynecologic ...

Mission Health has completed an expansion of its sub-specialty care clinic for women with cancer ...